QIAGEN
(Suzhou) Translational Medicine Co., Ltd. is an innovative company that provides
complete solutions for personalized healthcare through translational science,
to make improvement in life possible. The company was founded through
the collaboration of two distinguished entities in the biotech industry; QIAGEN,
the world leader in sample, assay and diagnostics technology and BioBAY, a
major science and technology hub for the development of the emerging biological
industry in China.
With
a state-of-the-art facility equipped with the most advanced technologies and
platforms as well as committed talents, QIAGEN (Suzhou) TMC offers our partners
with fully integrated solutions from biomarker discovery and development, to Companion
Diagnostics (CDx) and Point-of-Care (PoC) product development, and all the way
to clinical testing and commercialization through:
1)High quality patient samples/biobank
access in China with Qiagen standardized sampling workflow,and reliable clinical testing services
高品质的生物样本库和凯杰标准化样本制备流程以及可靠的临床检查服务
2)Fully integrated biomarker discovery
and development platform providing one-stop solution and a wide range of
services including both gene-based and protein-based biomarker testing with
multi-modal technology.
从基因到蛋白的整合生物标志物研发平台
3)Industry-leading bioinformatics applications
for the analysis, interpretation, and reporting of “omics” data.
业界领先的“组学”数据分析、解读及报告生成的一体化生物信息学工具
4)Validated diagnostic assays using
liquid and tissue biopsy for clinical trials and robust companion diagnostic
kits for commercialization.
适用于组织及体液样本的伴随诊断产品的研发及商品化平台
QIAGEN
(Suzhou) Translational Medicine Co., Ltd. is an innovative company that provides
complete solutions for personalized healthcare through translational science,
to make improvement in life possible. The company was founded through
the collaboration of two distinguished entities in the biotech industry; QIAGEN,
the world leader in sample, assay and diagnostics technology and BioBAY, a
major science and technology hub for the development of the emerging biological
industry in China.
With
a state-of-the-art facility equipped with the most advanced technologies and
platforms as well as committed talents, QIAGEN (Suzhou) TMC offers our partners
with fully integrated solutions from biomarker discovery and development, to Companion
Diagnostics (CDx) and Point-of-Care (PoC) product development, and all the way
to clinical testing and commercialization through:
1)High quality patient samples/biobank
access in China with Qiagen standardized sampling workflow,and reliable clinical testing services
高品质的生物样本库和凯杰标准化样本制备流程以及可靠的临床检查服务
2)Fully integrated biomarker discovery
and development platform providing one-stop solution and a wide range of
services including both gene-based and protein-based biomarker testing with
multi-modal technology.
从基因到蛋白的整合生物标志物研发平台
3)Industry-leading bioinformatics applications
for the analysis, interpretation, and reporting of “omics” data.
业界领先的“组学”数据分析、解读及报告生成的一体化生物信息学工具
4)Validated diagnostic assays using
liquid and tissue biopsy for clinical trials and robust companion diagnostic
kits for commercialization.